40th Annual Brain Impairment Conference of ASSBI
Looking back to look ahead: 40 years of science, practice and education in brain impairment.
1 - 3 June 2017 Grand Hyatt Melbourne Australia
Proudly supported by:
40th ASSBI Brain Impairment Conference 2017 MELBOURNE
Working together to improve the lives of people with brain impairment
CALL FOR ABSTRACTS
Abstract Submission has been extended to midnight on 10 February 2017 Submit Now via Easy Chair! – Using Easy Chair - Download this call for abstracts - ABSTRACTS MUST BE ATTACHED TO YOUR EASY CHAIR SUBMISSION Notification of acceptance will be made at the beginning of March 2017 The theme of this conference is: “Looking back to look ahead: 40 years of science, practice and education in brain impairment”. The conference will cover both clinical and laboratory studies relating to assessment and rehabilitation of individuals with brain impairment across the lifespan. It will also focus on how scientific evidence can be translated into clinical practice, particularly through education and training of clinicians. As ASSBI is a multidisciplinary society, we encourage researchers and health professionals in areas such as neuropsychology, clinical psychology, speech pathology, occupational therapy, physiotherapy, social work, neurology, psychiatry, rehabilitation and nursing to contribute and take part. Please note that in addition to the usual presentation types, submissions are sought for a new "how-to" presentation format being introduced at ASSBI this year. “How- to” sessions are 60-minute mini-masterclasses in which a leading practitioner will briefly give an update on a specific assessment or therapeutic approach, providing an opportunity for attendees to learn new skills. Abstracts may be submitted for Platform, Datablitz (5 minute oral plus poster), Symposium, “How to” session or Poster presentation formats (please see complete details in the section below). Prospective presenters are invited to indicate their preferred presentation format, although the final decision will be made by the scientific committee. All abstracts must consist of original work. Abstracts that have been previously published should not be submitted. All research, results, and conclusions should be final at the time of submission. There is no limitation on the number of submissions by one author; however, authors are asked to use discretion since submitting multiple abstracts may create scheduling problems. All submissions will be peer reviewed. The Program Committee Chair will make the final decision on all submissions. Accepted abstracts must be presented at the conference by an author or his/her designated representative. Any authors who will attend the conference must register for the conference and pay the appropriate conference registration fee. Abstracts that are accepted and presented at the conference will be available for delegates via the Smartphone App, on the ASSBI website and will be published in the Society’s Scientific Journal Brain Impairment. Abstracts will be published in ASSBI’s journal Brain Impairment and on the conference app exactly as submitted. Please proofread carefully before finalising your abstract submission. NOTE: If you do not attach your abstract it will not be reviewed and there will be ONE reminder only As there will be student awards and grants, please indicate your student status when submitting your abstract (in the topics section). To apply for one of the 4 student conference travel grants please go the ASSBI website AFTER you have submitted the abstract. The travel grants will be rated by the conference committee and awarded prior to the conference. The Awards will be rated by a sub-committee of the ASSBI Executive and awarded at the conference. To be eligible for all the awards you must attend the conference. Presentation Formats:  1. Platform sessions: Platform paper sessions comprise individual oral presentations, which are scheduled together with other thematically related platform papers at the discretion of the ASSBI Program Committee Chair. Between four and six individually submitted abstracts will be chosen for each paper session. Each abstract will be allotted 15 minutes for oral presentation and audience discussion. A moderator will rigorously adhere to these time limits to allow time for discussion. 2. Symposium sessions: Symposia are topical platform sessions arranged by a symposium chair that deal with a specific issue, thus creating an integrated series of presentations for the audience.  Each participant appears by the symposium chair’s invitation and presents material related to the topic nominated by the symposium chair. Abstracts for presentations within a symposium should be submitted by each presenter participating in the symposium, and they should tick “oral presentation”. The chair of the symposium should also submit an abstract outlining the symposium and listing the titles of the presentations in the symposium as well as nominating a discussant to discuss themes arising from the papers presented in the symposium. Symposium sessions are typically 90 minutes including discussant. 3. How to sessions: Submissions are sought for a new presentation format being introduced at ASSBI this year. “How-to” sessions are 60-minute mini-masterclasses in which a leading practitioner will briefly give an update on a specific assessment or therapeutic approach, providing an opportunity for attendees to learn new skills. Note that the layout for this submission differs from other presentation types, and can be found by clicking on the link below. It is important that the session’s learning objectives and the level of experience of the intended audience are clearly identified.  4. Datablitz sessions: Datablitz sessions include a 5 minute oral presentation and a Poster. The session is arranged prior to a break so delegates can hear the presentation and then go to the Poster and discuss with the author. 5. Poster sessions: The poster format has proven to be an effective and popular method for communication of scientific information. Poster sessions will be designed to provide a more intimate forum for informal discussion than is permitted by regular platform presentations. Poster presenters will stay with their poster for the duration of the poster session and are encouraged to bring handouts for interested viewers. The posters should be 100cm wide by 150cm long (no wider please) Submissions must be formatted according to the following guidelines: maximum 250 words Title: sentence case and bold; Authors: sentence case - surname, first name, superscript for affiliations; Affiliations: sentence case - department, institution, city, country; Abstract: structured abstract with the following headings in sentence case and bold: Background and Objectives, Method, Results Conclusions; All abbreviations should be written in full the first time; Correspondence: Corresponding author and email address; PLEASE DO NOT WRITE the words Title, Authors, Affiliations, Abstract For an example of how to layout your abstract see below for each specific session Please SUBMIT the abstract in WORD FORMAT electronically via Easy Chair  All inquiries regarding the conference should be referred to Margaret Eagers Abstract should be in this format single line spacing in Calibri 11pt PLEASE and attached to the submission where it says attach abstract Layout for Oral, Datablitz, Poster and abstracts within a symposium submission This is the title it is written in bold Surname, First name1,2; Surname, First name3 and Surname, First name4 1Department of Neurology, Royal North Shore Hospital, Sydney, Australia 2Northern Clinical School, Sydney Medical School, University of Sydney, Sydney, Australia                                       3Rehabilitation Studies Unit, Sydney Medical School, University of Sydney, Sydney, Australia                                                                                                                                                                      4Brain Injury Rehabilitation Unit, Liverpool Hospital, Sydney, Australia Background and aims: (in bold) Text of paragraph not bold. Method: (in bold) Text of paragraph not bold. Results: (in bold) Text of paragraph not bold.    Conclusions: (in bold) Text of paragraph not bold.   Correspondence: (in bold) First name Last name of corresponding author; email address of corresponding author (is not in bold) Layout for Symposium Submission This is the title of the symposium - it is written in bold Surname, First name of the CHAIR Institution of CHAIR Synopsis of Symposium List of abstracts included in the symposium (this should include: Title of submission; Name of corresponding author; Easy Chair Abstract number which is emailed to the corresponding author when their abstract is submitted) Correspondence: (in bold) First name Last name of CHAIR; email address of corresponding author (is not in bold) Layout for “How to” session submission  This is the title it is written in bold Surname, First name Institution Synopsis of session: Level aimed for: Basic, Intermediate, Experienced Learning objectives: List at least 2 learning outcomes a delegate can expect to obtain after attending this session Biography: A short bio – one short paragraph Correspondence: (in bold) First name Last name of corresponding author; email address of corresponding author (is not in bold) Example of oral/poster abstract: Do traditional tests of post-traumatic amnesia (PTA) tell us how early emergence from PTA really occurs? Perdices, Michael1,2; Tate, Robyn L.3 and Cassel, Anneli3 1Department of Neurology, Royal North Shore Hospital, Sydney, Australia 2Northern Clinical School, Sydney Medical School, University of Sydney, Sydney, Australia                                       3Rehabilitation Studies Unit, Sydney Medical School, University of Sydney, Sydney, Australia                                                                                                                                                                      Background and aims: Emergence from post-traumatic amnesia (PTA) on two commonly used tests (Modified Oxford/Westmead PTA Scales, MOPTAS/WPTAS) is defined as the first of three consecutive days of score 12/12, but there is no empirical evidence for this criterion.  Tate et al. (2006) had demonstrated that in severely injured patients (PTA duration ~10 weeks), there was no difference on a brief cognitive battery between the first and third occasion of score 12/12, suggesting that emergence from PTA occurs on the first occasion of score 12/12.  Method:   PTA was evaluated using the MOPTAS.  A sample (n=27) with PTA <5 weeks duration was assessed on three occasions with the same battery used in the previous study, along with the Galveston Orientation and Amnesia Test (GOAT) PTA test.  Testing occurred on three occasions: Time 1 (MOPTAS score 7/12), Time 2 (first 12/12), Time 3 (third consecutive 12/12).  Results:  PTA duration was M=15.7 days (SD=10.7).  Using Bonferroni corrections (p<0.01) there were significant differences between Time 1 and Time 2 on the GOAT but not on any cognitive test.  Between Time 2 and Time 3 difference in GOAT scores was not significant, but simple reaction time improved significantly.    Conclusions:  In contrast to patients with long PTA duration, patients with shorter PTA duration may have emerged from PTA much sooner than when they first score 12/12 score, and certainly much sooner than deemed by the traditional criterion.   Correspondence: Michael Perdices; mperdices@nsccahs.health.nsw.gov.au
Twitter: #assbi2017